Wiedenheft, B., Sternberg, S. H. & Doudna, J. A.
RNA-guided genetic silencing systems in bacteria and archaea. Nature
482, 331–338 (2012).
et al. piRNAs initiate an epigenetic memory of nonself RNA in the C. elegans germline. Cell
150, 65–77 (2012).
Lee, H. C.
et al. C. elegans piRNAs mediate the genome-wide surveillance of germline transcripts. Cell
150, 78–87 (2012).
et al. piRNAs can trigger a multigenerational epigenetic memory in the germline of C. elegans. Cell
150, 88–99 (2012).
Marraffini, L. A. & Sontheimer, E. J.
CRISPR interference: RNA-directed adaptive immunity in bacteria and archaea. Nature Rev. Genet.
11, 181–190 (2010).
Siomi, M. C., Sato, K., Pezic, D. & Aravin, A. A.
PIWI-interacting small RNAs: the vanguard of genome defence. Nature Rev. Mol. Cell Biol.
12, 246–258 (2011).
Ding, S. W.
RNA-based antiviral immunity. Nature Rev. Immunol.
10, 632–644 (2010).
Ebert, M. S. & Sharp, P. A.
Roles for MicroRNAs in conferring robustness to biological processes. Cell
149, 515–524 (2012).
Friedman, R. C., Farh, K. K., Burge, C. B. & Bartel, D. P.
Most mammalian mRNAs are conserved targets of microRNAs. Genome Res.
19, 92–105 (2009).
Ishizu, H., Siomi, H. & Siomi, M. C.
Biology of PIWI-interacting RNAs: new insights into biogenesis and function inside and outside of germlines. Genes Dev.
26, 2361–2373 (2012).
Bartel, D. P.
MicroRNAs: genomics, biogenesis, mechanism, and function. Cell
116, 281–297 (2004). A comprehensive review discussing the biology of miRNAs.
Ding, S. W. & Voinnet, O.
Antiviral immunity directed by small RNAs. Cell
130, 413–426 (2007). A thorough review discussing the use of sRNAs in plants, nematodes and arthropods.
Brodersen, P. & Voinnet, O.
The diversity of RNA silencing pathways in plants. Trends Genet.
22, 268–280 (2006).
Vaistij, F. E., Jones, L. & Baulcombe, D. C.
Spreading of RNA targeting and DNA methylation in RNA silencing requires transcription of the target gene and a putative RNA-dependent RNA polymerase. Plant Cell
14, 857–867 (2002).
et al. On the role of RNA amplification in dsRNA-triggered gene silencing. Cell
107, 465–476 (2001).
Rechavi, O., Minevich, G. & Hobert, O.
Transgenerational inheritance of an acquired small RNA-based antiviral response in C. elegans. Cell
147, 1248–1256 (2011).
Saleh, M. C.
et al. Antiviral immunity in Drosophila requires systemic RNA interference spread. Nature
458, 346–350 (2009). The first evidence that siRNAs can be secreted and function throughout arthropods despite the absence of an RdRp.
Lee, R. C. & Ambros, V.
An extensive class of small RNAs in Caenorhabditis elegans. Science
294, 862–864 (2001).
Lau, N. C., Lim, L. P., Weinstein, E. G. & Bartel, D. P.
An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science
294, 858–862 (2001).
Lagos-Quintana, M., Rauhut, R., Lendeckel, W. & Tuschl, T.
Identification of novel genes coding for small expressed RNAs. Science
294, 853–858 (2001).
Lund, E., Guttinger, S., Calado, A., Dahlberg, J. E. & Kutay, U.
Nuclear export of microRNA precursors. Science
303, 95–98 (2004).
Yi, R., Qin, Y., Macara, I. G. & Cullen, B. R.
Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev.
17, 3011–3016 (2003).
Bernstein, E., Caudy, A. A., Hammond, S. M. & Hannon, G. J.
Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature
409, 363–366 (2001).
et al. Genes and mechanisms related to RNA interference regulate expression of the small temporal RNAs that control C. elegans developmental timing. Cell
106, 23–34 (2001).
Ketting, R. F.
et al. Dicer functions in RNA interference and in synthesis of small RNA involved in developmental timing in C. elegans. Genes Dev.
15, 2654–2659 (2001).
et al. A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science
293, 834–838 (2001).
Schwarz, D. S.
et al. Asymmetry in the assembly of the RNAi enzyme complex. Cell
115, 199–208 (2003).
Khvorova, A., Reynolds, A. & Jayasena, S. D.
Functional siRNAs and miRNAs exhibit strand bias. Cell
115, 209–216 (2003).
Zeng, Y., Wagner, E. J. & Cullen, B. R.
Both natural and designed micro RNAs can inhibit the expression of cognate mRNAs when expressed in human cells. Mol. Cell
9, 1327–1333 (2002). The first rigorous demonstration that miRNAs can be artificially designed and elicit silencing.
et al. The impact of microRNAs on protein output. Nature
455, 64–71 (2008).
et al. Widespread changes in protein synthesis induced by microRNAs. Nature
455, 58–63 (2008).
et al. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol. Cell
27, 91–105 (2007).
Giraldez, A. J.
et al. Zebrafish miR-430 promotes deadenylation and clearance of maternal mRNAs. Science
312, 75–79 (2006).
Lim, L. P.
et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature
433, 769–773 (2005).
et al. Silencing of microRNAs in vivo with 'antagomirs'. Nature
438, 685–689 (2005).
Lewis, B. P., Burge, C. B. & Bartel, D. P.
Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell
120, 15–20 (2005).
Bartel, D. P.
MicroRNAs: target recognition and regulatory functions. Cell
136, 215–233 (2009).
et al. Expanding the microRNA targeting code: functional sites with centered pairing. Mol. Cell
38, 789–802 (2010).
Chi, S. W., Hannon, G. J. & Darnell, R. B.
An alternative mode of microRNA target recognition. Nature Struct. Mol. Biol.
19, 321–327 (2012).
Haasnoot, J., Westerhout, E. M. & Berkhout, B.
RNA interference against viruses: strike and counterstrike. Nature Biotech.
25, 1435–1443 (2007).
Cullen, B. R.
Viruses and microRNAs: RISCy interactions with serious consequences. Genes Dev.
25, 1881–1894 (2011). A discussion of the physiologogical interplay between viruses and miRNAs.
et al. Effects of Dicer and Argonaute down-regulation on mRNA levels in human HEK293 cells. Nucleic Acids Res.
34, 4801–4815 (2006).
et al. Molecular characterization of human Argonaute-containing ribonucleoprotein complexes and their bound target mRNAs. RNA
14, 2580–2596 (2008).
Brown, B. D.
et al. Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, lineage and differentiation state. Nature Biotech.
25, 1457–1467 (2007).
et al. High-throughput assessment of microRNA activity and function using microRNA sensor and decoy libraries. Nature Methods
9, 840–846 (2012).
Langlois, R. A., Shapiro, J. S., Pham, A. M. & tenOever, B. R.
In vivo delivery of cytoplasmic RNA virus-derived miRNAs. Mol. Ther.
20, 367–375 (2011).
Perez, J. T.
et al. Influenza A virus-generated small RNAs regulate the switch from transcription to replication. Proc. Natl Acad. Sci. USA
107, 11525–11530 (2010).
et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell
129, 1401–1414 (2007).
Jackson, A. L.
et al. Expression profiling reveals off-target gene regulation by RNAi. Nature Biotech.
21, 635–637 (2003).
Jackson, A. L. & Linsley, P. S.
Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application. Nature Rev. Drug Discov.
9, 57–67 (2010).
Pedersen, I. M.
et al. Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature
449, 919–922 (2007).
et al. Hypersusceptibility to vesicular stomatitis virus infection in Dicer1-deficient mice is due to impaired miR24 and miR93 expression. Immunity
27, 123–134 (2007).
Buggele, W. A., Johnson, K. E. & Horvath, C. M.
Influenza A virus infection of human respiratory cells induces primary microRNA expression. J. Biol. Chem.
287, 31027–31040 (2012).
Haley, B. & Zamore, P. D.
Kinetic analysis of the RNAi enzyme complex. Nature Struct. Mol. Biol.
11, 599–606 (2004).
et al. Identification of microRNAs of the herpesvirus family. Nature Methods
2, 269–276 (2005).
et al. Identification of virus-encoded microRNAs. Science
304, 734–736 (2004).
et al. Six RNA viruses and forty-one hosts: viral small RNAs and modulation of small RNA repertoires in vertebrate and invertebrate systems. PLoS Pathog.
666, e1000764 (2010).
Jopling, C. L., Norman, K. L. & Sarnow, P.
Positive and negative modulation of viral and cellular mRNAs by liver-specific microRNA miR-122. Cold Spring Harb. Symp. Quant. Biol.
71, 369–376 (2006).
et al. Stabilization of hepatitis C virus RNA by an Ago2–miR-122 complex. Proc. Natl Acad. Sci. USA
109, 941–946 (2012).
Jopling, C. L., Schutz, S. & Sarnow, P.
Position-dependent function for a tandem microRNA miR-122-binding site located in the hepatitis C virus RNA genome. Cell Host Microbe
4, 77–85 (2008).
Machlin, E. S., Sarnow, P. & Sagan, S. M.
Masking the 5′ terminal nucleotides of the hepatitis C virus genome by an unconventional microRNA-target RNA complex. Proc. Natl Acad. Sci. USA
108, 3193–3198 (2011).
et al. Proteome half-life dynamics in living human cells. Science
331, 764–768 (2011).
O'Connell, R. M., Taganov, K. D., Boldin, M. P., Cheng, G. & Baltimore, D.
MicroRNA-155 is induced during the macrophage inflammatory response. Proc. Natl Acad. Sci. USA
104, 1604–1609 (2007).
et al. Integrative deep sequencing of the mouse lung transcriptome reveals differential expression of diverse classes of small RNAs in response to respiratory virus infection. mBio
2, e00198–11 (2011).
et al. Murine cytomegalovirus encodes a miR-27 inhibitor disguised as a target. Proc. Natl Acad. Sci. USA
109, 279–284 (2012).
Cazalla, D., Yario, T. & Steitz, J. A.
Down-regulation of a host microRNA by a Herpesvirus saimiri noncoding RNA. Science
328, 1563–1566 (2010).
et al. Degradation of cellular mir-27 by a novel, highly abundant viral transcript is important for efficient virus replication in vivo. PLoS Pathog.
866, e1002510 (2012).
Cullen, B. R.
Herpesvirus microRNAs: phenotypes and functions. Curr. Opin. Virol.
1, 211–215 (2011).
et al. Degradation of host microRNAs by poxvirus poly(A) polymerase reveals terminal RNA methylation as a protective antiviral mechanism. Cell Host Microbe
12, 200–210 (2012).
et al. Competition for XPO5 binding between Dicer mRNA, pre-miRNA and viral RNA regulates human Dicer levels. Nature Struct. Mol. Biol.
18, 323–327 (2011).
Lu, S. & Cullen, B. R.
Adenovirus VA1 noncoding RNA can inhibit small interfering RNA and MicroRNA biogenesis. J. Virol.
78, 12868–12876 (2004).
Voinnet, O., Pinto, Y. M. & Baulcombe, D. C.
Suppression of gene silencing: a general strategy used by diverse DNA and RNA viruses of plants. Proc. Natl Acad. Sci. USA
96, 14147–14152 (1999).
Li, W. X.
et al. Interferon antagonist proteins of influenza and vaccinia viruses are suppressors of RNA silencing. Proc. Natl. Acad. Sci. USA
101, 1350–1355 (2004).
Delgadillo, M. O., Saenz, P., Salvador, B., Garcia, J. A. & Simon-Mateo, C.
Human influenza virus NS1 protein enhances viral pathogenicity and acts as an RNA silencing suppressor in plants. J. Gen. Virol.
85, 993–999 (2004).
Bucher, E., Hemmes, H., de Haan, P., Goldbach, R. & Prins, M.
The influenza A virus NS1 protein binds small interfering RNAs and suppresses RNA silencing in plants. J. Gen. Virol.
85, 983–991 (2004).
Langlois, R. A., Varble, A., Chua, M. A., Garcia-Sastre, A. & tenOever, B. R.
Hematopoietic-specific targeting of influenza A virus reveals replication requirements for induction of antiviral immune responses. Proc. Natl Acad. Sci. USA
109, 12117–12122 (2012).
Perez, J. T.
et al. MicroRNA-mediated species-specific attenuation of influenza A virus. Nature Biotech.
27, 572–576 (2009).
Garcia-Sastre, A. & Biron, C. A.
Type 1 interferons and the virus-host relationship: a lesson in détente. Science
312, 879–882 (2006).
Barnes, D., Kunitomi, M., Vignuzzi, M., Saksela, K. & Andino, R.
Harnessing endogenous miRNAs to control virus tissue tropism as a strategy for developing attenuated virus vaccines. Cell Host Microbe
4, 239–248 (2008).
Brown, B. D., Venneri, M. A., Zingale, A., Sergi Sergi, L. & Naldini, L.
Endogenous microRNA regulation suppresses transgene expression in hematopoietic lineages and enables stable gene transfer. Nature Med.
12, 585–591 (2006).
Gottwein, E., Cai, X. & Cullen, B. R.
A novel assay for viral microRNA function identifies a single nucleotide polymorphism that affects Drosha processing. J. Virol.
80, 5321–5326 (2006).
et al. Engineered lentiviral vector targeting astrocytes in vivo. Glia
57, 667–679 (2009).
Papapetrou, E. P., Kovalovsky, D., Beloeil, L., Sant'angelo, D. & Sadelain, M.
Harnessing endogenous miR-181a to segregate transgenic antigen receptor expression in developing versus post-thymic T cells in murine hematopoietic chimeras. J. Clin. Invest.
119, 157–168 (2009).
Heiss, B. L., Maximova, O. A., Thach, D. C., Speicher, J. M. & Pletnev, A. G.
MicroRNA targeting of neurotropic flavivirus: effective control of virus escape and reversion to neurovirulent phenotype. J. Virol.
86, 5647–5659 (2012).
Heiss, B. L., Maximova, O. A. & Pletnev, A. G.
Insertion of microRNA targets into the flavivirus genome alters its highly neurovirulent phenotype. J. Virol.
85, 1464–1472 (2010).
Kelly, E. J., Nace, R., Barber, G. N. & Russell, S. J.
Attenuation of vesicular stomatitis virus encephalitis through microRNA targeting. J. Virol.
84, 1550–1562 (2009).
Edge, R. E.
et al. A let-7 microRNA-sensitive vesicular stomatitis virus demonstrates tumor-specific replication. Mol. Ther.
16, 1437–1443 (2008).
Leber, M. F.
et al. MicroRNA-sensitive oncolytic measles viruses for cancer-specific vector tropism. Mol. Ther.
19, 1097–1106 (2011).
Pham, A. M., Langlois, R. A. & tenOever, B. R.
Replication in cells of hematopoietic origin is necessary for Dengue virus dissemination. PLoS Pathog.
866, e1002465 (2012).
et al. Stable knockdown of microRNA in vivo by lentiviral vectors. Nature Methods
6, 63–66 (2009).
Ameres, S. L.
et al. Target RNA-directed trimming and tailing of small silencing RNAs. Science
328, 1534–1539 (2010).
et al. Long-term, efficient inhibition of microRNA function in mice using rAAV vectors. Nature Methods
9, 403–409 (2012).
Salmena, L., Poliseno, L., Tay, Y., Kats, L. & Pandolfi, P. P.
A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language?
146, 353–358 (2011).
Elbashir, S. M.
et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature
411, 494–498 (2001).
Whitehead, K. A., Langer, R. & Anderson, D. G.
Knocking down barriers: advances in siRNA delivery. Nature Rev. Drug Discov.
8, 129–138 (2009).
Kincaid, R. P., Burke, J. M. & Sullivan, C. S.
RNA virus microRNA that mimics a B-cell oncomiR. Proc. Natl Acad. Sci. USA
109, 3077–3082 (2012).
Seo, G. J., Chen, C. J. & Sullivan, C. S.
Merkel cell polyomavirus encodes a microRNA with the ability to autoregulate viral gene expression. Virology
383, 183–187 (2009).
et al. Combinatorial delivery of small interfering RNAs reduces RNAi efficacy by selective incorporation into RISC. Nucleic Acids Res.
35, 5154–5164 (2007).
Chang, K., Elledge, S. J. & Hannon, G. J.
Lessons from nature: microRNA-based shRNA libraries. Nature Methods
3, 707–714 (2006). A overview of how miRNAs can be redesigned to express an sRNA of interest.
Silva, J. M.
et al. Second-generation shRNA libraries covering the mouse and human genomes. Nature Genet.
37, 1281–1288 (2005).
Xia, H., Mao, Q., Paulson, H. L. & Davidson, B. L.
siRNA-mediated gene silencing in vitro and in vivo. Nature Biotech.
20, 1006–1010 (2002).
Lee, M. T., Coburn, G. A., McClure, M. O. & Cullen, B. R.
Inhibition of human immunodeficiency virus type 1 replication in primary macrophages by using Tat- or CCR5-specific small interfering RNAs expressed from a lentivirus vector. J. Virol.
77, 11964–11972 (2003).
Stewart, S. A.
et al. Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA
9, 493–501 (2003).
Castanotto, D. & Rossi, J. J.
The promises and pitfalls of RNA-interference-based therapeutics. Nature
457, 426–433 (2009).
et al. Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature
441, 537–541 (2006). The first evidence that overproduction of sRNAs can result in significant toxicity owing to saturation of the host machinery.
Kleinman, M. E.
et al. Sequence- and target-independent angiogenesis suppression by siRNA via TLR3. Nature
452, 591–597 (2008).
Sledz, C. A., Holko, M., de Veer, M. J., Silverman, R. H. & Williams, B. R.
Activation of the interferon system by short-interfering RNAs. Nature Cell Biol.
5, 834–839 (2003).
Bridge, A. J., Pebernard, S., Ducraux, A., Nicoulaz, A. L. & Iggo, R.
Induction of an interferon response by RNAi vectors in mammalian cells. Nature Genet.
34, 263–264 (2003).
Kim, D. H.
et al. Interferon induction by siRNAs and ssRNAs synthesized by phage polymerase. Nature Biotech.
22, 321–325 (2004).
et al. 5′-triphosphate RNA is the ligand for RIG-I. Science
314, 994–997 (2006).
et al. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science
314, 997–1001 (2006).
et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature
441, 101–105 (2006).
Marques, J. T.
et al. A structural basis for discriminating between self and nonself double-stranded RNAs in mammalian cells. Nature Biotech.
24, 559–565 (2006).
Judge, A. D.
et al. Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA. Nature Biotech.
23, 457–462 (2005).
Yi, R., Doehle, B. P., Qin, Y., Macara, I. G. & Cullen, B. R.
Overexpression of exportin 5 enhances RNA interference mediated by short hairpin RNAs and microRNAs. RNA
11, 220–226 (2005).
et al. Argonaute proteins are key determinants of RNAi efficacy, toxicity, and persistence in the adult mouse liver. J. Clin. Invest.
120, 3106–3119 (2010).
Khan, A. A.
et al. Transfection of small RNAs globally perturbs gene regulation by endogenous microRNAs. Nature Biotech.
27, 549–555 (2009).
et al. Competition for RISC binding predicts in vitro potency of siRNA. Nucleic Acids Res.
34, 4467–4476 (2006).
Vickers, T. A., Lima, W. F., Nichols, J. G. & Crooke, S. T.
Reduced levels of Ago2 expression result in increased siRNA competition in mammalian cells. Nucleic Acids Res.
35, 6598–6610 (2007).
et al. Low-level shRNA cytotoxicity can contribute to MYC-induced hepatocellular carcinoma in adult mice. Mol. Ther.
18, 161–170 (2010).
McBride, J. L.
et al. Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi. Proc. Natl Acad. Sci. USA
105, 5868–5873 (2008).
Boudreau, R. L., Martins, I. & Davidson, B. L.
Artificial microRNAs as siRNA shuttles: improved safety as compared to shRNAs in vitro and in vivo. Mol. Ther.
17, 169–175 (2009).
Schnell, M. A.
et al. Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectors. Mol. Ther.
3, 708–722 (2001).
et al. Effect of adenovirus-mediated RNA interference on endogenous microRNAs in a mouse model of multidrug resistance protein 2 gene silencing. J. Virol.
80, 12236–12247 (2006).
Wu, X., Li, Y., Crise, B. & Burgess, S. M.
Transcription start regions in the human genome are favored targets for MLV integration. Science
300, 1749–1751 (2003).
et al. Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration. Nature Biotech.
24, 687–696 (2006).
Small silencing RNAs: state-of-the-art. Adv. Drug Deliv. Rev.
61, 672–703 (2009).
et al. Adeno-associated viral vector-mediated gene transfer of human blood coagulation factor IX into mouse liver. Blood
91, 4600–4607 (1998).
Flotte, T. R.
et al. Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector. Proc. Natl Acad. Sci. USA
90, 10613–10617 (1993).
Kaplitt, M. G.
et al. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nature Genet.
8, 148–154 (1994).
Rouha, H., Thurner, C. & Mandl, C. W.
Functional microRNA generated from a cytoplasmic RNA virus. Nucleic Acids Res.
38, 8328–8337 (2010).
Shapiro, J. S., Varble, A., Pham, A. M. & tenOever, B. R.
Noncanonical cytoplasmic processing of viral microRNAs. RNA
16, 2068–2074 (2010). This and reference 131 demonstrate that pri-miRNAs can be generated by engineered cytoplasmic viruses.
Shapiro, J. S., Langlois, R. A., Pham, A. M. & tenOever, B. R.
Evidence for a cytoplasmic microprocessor of pri-miRNAs. RNA
18, 1338–1346 (2012). The first article to address the mechanism enabling cytoplasmic synthesis of pri-miRNAs.
et al. Engineered RNA viral synthesis of microRNAs. Proc. Natl Acad. Sci. USA
107, 11519–11524 (2010).
et al. West Nile virus encodes a microRNA-like small RNA in the 3′ untranslated region which up-regulates GATA4 mRNA and facilitates virus replication in mosquito cells. Nucleic Acids Res.
40, 2210–2223 (2012).
Westerhout, E. M., Ooms, M., Vink, M., Das, A. T. & Berkhout, B.
HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome. Nucleic Acids Res.
33, 796–804 (2005).
Russell, S. J., Peng, K. W. & Bell, J. C.
Oncolytic virotherapy. Nature Biotech.
30, 658–670 (2012). A comprehensive review discussing the use of lytic viruses to treat cancer.
Judson, R. L., Babiarz, J. E., Venere, M. & Blelloch, R.
Embryonic stem cell-specific microRNAs promote induced pluripotency. Nature Biotech.
27, 459–461 (2009).
et al. Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell
8, 376–388 (2011).
Farh, K. K.
et al. The widespread impact of mammalian microRNAs on mRNA repression and evolution. Science
310, 1817–1821 (2005).
Stark, A., Brennecke, J., Bushati, N., Russell, R. B. & Cohen, S. M.
Animal microRNAs confer robustness to gene expression and have a significant impact on 3′UTR evolution. Cell
123, 1133–1146 (2005).
Tsang, J., Zhu, J. & van Oudenaarden, A.
MicroRNA-mediated feedback and feedforward loops are recurrent network motifs in mammals. Mol. Cell
26, 753–767 (2007).
Shkumatava, A., Stark, A., Sive, H. & Bartel, D. P.
Coherent but overlapping expression of microRNAs and their targets during vertebrate development. Genes Dev.
23, 466–481 (2009).
Cerutti, H. & Casas-Mollano, J. A.
On the origin and functions of RNA-mediated silencing: from protists to man. Curr. Genet.
50, 81–99 (2006).
et al. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J. Exp. Med.
205, 1601–1610 (2008).
et al. Potent effect of target structure on microRNA function. Nature Struct. Mol. Biol.
14, 287–294 (2007).
Jackson, A. L.
et al. Widespread siRNA “off-target” transcript silencing mediated by seed region sequence complementarity. RNA
12, 1179–1187 (2006).
et al. Nucleotide sequence homology requirements of HIV-1-specific short hairpin RNA. Nucleic Acids Res.
31, 6444–6449 (2003).
et al. Functional identification of optimized RNAi triggers using a massively parallel sensor assay. Mol. Cell
41, 733–746 (2011).
Makeyev, E. V., Zhang, J., Carrasco, M. A. & Maniatis, T.
The microRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing. Mol. Cell
27, 435–448 (2007).